Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company with a market capitalization of $113.7 billion, is navigating a critical juncture as it seeks to expand its therapeutic reach and ...
(NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today released the findings of their 2024 U.S. state and local End-of-Year Rates and Rules Report. It ...
PRNewswire New Delhi [India] January 24 Attentiveai a leading AI-based SaaS startup today announced the successful close of its Series A2 funding round completing a 12M raise in Series A in two tranch ...